Today's a good day for gadget enthusiasts. During its I/O event, Google announced that like Microsoft, it was jumping into the tablet market. The search giant made three big announcements: The Nexus 7, its tablet; the Nexus Q, a streaming device; and a new version of its mobile operating system called Jelly Bean.
The Russian government is facing a growing chorus of criticism over its harsh treatment of three women from an all-female rock band who staged a "punk" prayer service last winter in Moscow's most prominent cathedral.
Back on Feb. 21, two weeks before Russia's presidential election, several members of the band Pussy Riot, wearing brightly colored balaclavas, rushed onto the altar of the Cathedral of Christ the Savior.
Clementines and pelvic anatomy are two things you probably wouldn't ever talk about in the same sentence, unless you're Pamela Andreatta.
Andreatta, a medical educator at the University of Michigan Medical School, knows all about how people learn. And lately, she's been spending a lot of time scrutinizing how residents are taught to do minimally invasive surgery.
Several dozen people know how the Supreme Court will rule on the constitutionality of President Obama's health care law. And it'll stay that way until sometime after 10 a.m. ET on Thursday, when the court releases its opinion to the rest of us.
The decision will have broad societal, economic and legal ramifications, and will play a featured role in the November presidential election. But the justices and their young law clerks — the only ones privy to the deliberations — don't leak opinions. It's virtually unheard of.
We don't know what this says about the relationship between humans and robots. But researchers at the Ishikawa Oku Lab at the University of Toyko have developed a robot hand that can beat a human 100 percent of the time in a game of "rock, paper, scissors."
The biggest surprise Thursday morning at the Supreme Court will be if the justices do not issue their most-anticipated decision of the year — on the constitutionality of the Affordable Care Act; the health care overhaul enacted in 2010.
The FDA gave the green light to Arena Pharmaceuticals to sell Belviq, or lorcaserin generically, a twice-a-day pill that suppresses appetite and appears to affect metabolism by influencing levels of the brain chemical serotonin.